JESSICA DALE: Open Payments
NPI 1346818937 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 25 payments from 9 companies in 2025. Trend: 2023 $828 · 2024 $565 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $143 |
| Regeneron Healthcare Solutions, Inc. | 3 | $97 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Organon LLC | 3 | $40 |
| GENZYME CORPORATION | 1 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
| Incyte Corporation | 1 | $16 |
| Janssen Biotech, Inc. | 1 | $15 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: DUPIXENT, SKYRIZI, COSENTYX, ILUMYA, RINVOQ, OPZELURA, TREMFYA, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
